By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cellular Dynamics International (CDI) has reeled in $40.6 million in Series B private equity funding, the pluripotent stem cell developer said today.

The company plans to use the financing, which came from Sam Zell's Equity Group Investments and Sixth Floor Investors, to increase production capacity for its iCell Cardiomyocytes, which are human heart cells derived from induced pluripotent stem cells (iPSCs).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.